07
Jul
2009
Taris Biomedical, Inc.: Series A $15M
Posted in I - Series A, Q - 2Q09, R - NORTH EAST, X - Drug:Device Combo, X - Interstitial Cystitis, XX - MA
Taris Biomedical (Lexington, MA) a preclinical-stage drug:device company focused on interstitial cystitis, close a $15M Series A financing. Participants include Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.
OnBioVC PARTNERS
-
